ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
19.84
+0.72 (3.77%)
At close: Sep 2, 2025, 4:00 PM
20.20
+0.36 (1.81%)
After-hours: Sep 2, 2025, 4:56 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $804.89 million as of September 2, 2025. Its market cap has increased by 0.44% in one year.
Market Cap
804.89M
Enterprise Value
569.30M
1-Year Change
0.44%
Ranking
Category
Stock Price
$19.84
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $804.89M, an increase of 39.93%. That is a compound annual growth rate of 23.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 804.89M | -10.34% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |